MedShare

Advanced Search

Investigating the consequences of BCR signalling inhibition on CLL tumour cells of patients treated with ibrutinib BTK inhibitors

Investigating the consequences of BCR signalling inhibition on CLL tumour cells of patients treated with ibrutinib BTK inhibitors

Research Project Report (2015-2016)

Author: Mr Perry Sissons
Supervisor: Francesco Forconi, Sam Drennan
Group: Haematology
Keywords: ibrutinib, bcr, expression, surface marker, signalling, chronic lymphocytic leukaemia (cll)

Toolbox